select search filters
roundups & rapid reactions
before the headlines
Fiona fox's blog

An update from the Comparing COVID-19 Vaccine Schedule Combinations (Com-COV) study

Matthew Snape, lead investigator on the Com-COV study, updated science journalists on some early reactogenicity results and answered their questions about the findings. The correspondence article has been published in the Lancet.


Speakers included:

Prof Matthew Snape, Associate Professor in paediatrics and vaccinology, Oxford Vaccine Group, Chief Investigator on the trial

in this section

filter Briefings by year

search by tag